Dr. Ludwig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12333 NE 130th Ln
Ste Tan
Kirkland, WA 98034Phone+1 206-543-3687
Education & Training
University of WashingtonResidency, Surgery, 2013 - 2018
The University of Texas Health Science Center at San AntonioClass of 2013
Certifications & Licensure
WA State Medical License 2021 - 2025- American Board of Surgery Surgery
Publications & Presentations
PubMed
- 2 citationsGlypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinoma.Kevin P Labadie, Adrienne L Lehnert, Aimee L Kenoyer, Donald K Hamlin, Andrew D Ludwig
EJNMMI Research. 2023-04-27 - 8 citationsGlypican-3 targeted thorium-227 alpha therapy reduces tumor burden in an orthotopic xenograft murine model of hepatocellular carcinoma.Kevin P. Labadie, Donald K. Hamlin, Aimee L. Kenoyer, Sara K. Daniel, Alan F. Utria
Journal of Nuclear Medicine. 2021-11-12 - 7 citationsGlypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinomaKevin P. Labadie, Andrew D. Ludwig, Adrienne L. Lehnert, Donald K. Hamlin, Aimee L. Kenoyer
Scientific Reports. 2021-02-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
